Can overnight stenting be safely eliminated following a pharyngeal flap? A matched comparison study

Andre M Wineland1, Jareen Meinzen-Derr2, Paul Willging3

  • 1University of Arkansas School for Medical Sciences, Department of Otolaryngology-Head and Neck Surgery, Division of Pediatric Otolaryngology, Arkansas Children's Hospital, Little Rock, Arkansas.

The Laryngoscope
|November 22, 2017
PubMed

Insights

Overnight stenting after pharyngeal flap surgery for pediatric velopharyngeal insufficiency (VPI) is not beneficial. Removing nasal stents on postoperative day 0 led to earlier discharge and improved oral intake compared to removal on postoperative day 1.

Area of Science:

  • Otolaryngology
  • Pediatric Surgery
  • Speech-Language Pathology

Background:

  • Velopharyngeal insufficiency (VPI) affects speech and can be managed with a pharyngeal flap.
  • Postoperative management, including nasal stenting, requires optimization for pediatric patients.

Purpose of the Study:

  • To determine if overnight stenting is necessary after pharyngeal flap surgery for pediatric VPI.
  • To compare outcomes based on the timing of nasal stent removal.

Main Methods:

  • Retrospective, age-matched cohort study of pediatric patients undergoing pharyngeal flap surgery for VPI.
  • Patients were divided into two groups based on nasal stent removal: postoperative day (POD) 0 or POD 1.
  • Primary outcome was postoperative oxygen desaturation; secondary outcomes included length of stay, narcotic use, and oral intake.

Main Results:

  • No significant difference in oxygen desaturation between groups.
  • Patients with stent removal on POD 0 had a significantly shorter hospital stay (P < 0.0001) and greater oral intake on POD 0 (P = 0.03).
  • The POD 0 group had a higher prevalence of genetic syndromes (P = 0.02).

Conclusions:

  • Overnight stenting offers no apparent benefit for pediatric patients undergoing pharyngeal flap surgery for VPI.
  • Early removal of nasal stents (POD 0) is associated with improved patient outcomes, including earlier hospital discharge.
  • No adverse events such as reintubation or hemorrhage were observed with early stent removal.
Abstract

Related Concept Videos